company background image
VIV.H logo

Avivagen TSXV:VIV.H Stock Report

Last Price

CA$0.005

Market Cap

CA$387.5k

7D

0%

1Y

-66.7%

Updated

30 Jul, 2024

Data

Company Financials

Avivagen Inc.

TSXV:VIV.H Stock Report

Market Cap: CA$387.5k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

VIV.H Stock Overview

Focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity.

About the company

VIV.H fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Rewards

Risk Analysis

Shares are highly illiquid
Earnings have declined by 4.6% per year over past 5 years
Negative shareholders equity
Makes less than USD$1m in revenue (CA$715K)

+ 2 more risks

Avivagen Inc. Competitors

Lowell Farms

CNSX:LOWL

CA$190.3k

Sweet Earth Holdings

CNSX:SE

CA$192.0k

Medcolcanna Organics

CNSX:MCCN

CA$848.7k

Gnomestar Craft

CNSX:GNOM

CA$854.1k

Price History & Performance

Summary of all time highs, changes and price drops for Avivagen
Historical stock prices
Current Share PriceUS$0.005
52 Week HighUS$0.02
52 Week LowUS$0.005
Beta-0.21
11 Month Changen/a
3 Month Changen/a
1 Year Change-66.67%
33 Year Change-98.57%
5 Year Change-99.19%
Change since IPO-99.76%

Recent News & Updates

Recent updates

It's Unlikely That Avivagen Inc.'s (CVE:VIV) CEO Will See A Huge Pay Rise This Year

Apr 02
It's Unlikely That Avivagen Inc.'s (CVE:VIV) CEO Will See A Huge Pay Rise This Year

Shareholder Returns

VIV.HCA PharmaceuticalsCA Market
7D0%0.7%0.6%
1Y-66.7%-1.7%23.3%

Return vs Industry: VIV.H underperformed the Canadian Pharmaceuticals industry which returned 32.2% over the past year.

Return vs Market: VIV.H underperformed the Canadian Market which returned 10.4% over the past year.

Price Volatility

Is VIV.H's price volatile compared to industry and market?
VIV.H volatility
VIV.H Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement10.2%
Market Average Movement8.3%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market3.1%

Stable Share Price: VIV.H has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine VIV.H's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aG. F. Anthonywww.avivagen.com

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand.

Avivagen Inc. Fundamentals Summary

How do Avivagen's earnings and revenue compare to its market cap?
VIV.H fundamental statistics
Market capCA$387.48k
Earnings (TTM)-CA$4.64m
Revenue (TTM)CA$715.22k

0.5x

P/S Ratio

-0.1x

P/E Ratio

Is VIV.H overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIV.H income statement (TTM)
RevenueCA$715.22k
Cost of RevenueCA$409.83k
Gross ProfitCA$305.39k
Other ExpensesCA$4.95m
Earnings-CA$4.64m

Last Reported Earnings

Jul 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.06
Gross Margin42.70%
Net Profit Margin-648.74%
Debt/Equity Ratio-78.1%

How did VIV.H perform over the long term?

See historical performance and comparison